SVRA ▲ +0.6% - Savara Inc. $SVRA Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment 21-OCT-2026 01:11 PM ET